Status: Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
Participants needed: 83
Trial details
Age: 50+Biological sex: AllType: ObservationalSponsor: Skyline TherapeuticsUpdated: Apr 4, 2024Locations: 10
Eligibility criteria
nAMD subjects who have been enrolled in the SKG0106-related study and received S... [+1]
Subjects who are judged by the investigator unsuitable for this study